ATE419859T1 - Verwendung von probiotischen bakterien zur herstellung von topischen zusammensetzungen zum schutz der haut - Google Patents

Verwendung von probiotischen bakterien zur herstellung von topischen zusammensetzungen zum schutz der haut

Info

Publication number
ATE419859T1
ATE419859T1 AT05778952T AT05778952T ATE419859T1 AT E419859 T1 ATE419859 T1 AT E419859T1 AT 05778952 T AT05778952 T AT 05778952T AT 05778952 T AT05778952 T AT 05778952T AT E419859 T1 ATE419859 T1 AT E419859T1
Authority
AT
Austria
Prior art keywords
skin
topical compositions
protect
probiotic bacteria
produce topical
Prior art date
Application number
AT05778952T
Other languages
English (en)
Inventor
Giancarla Dondi
Patrizia Malfa
Original Assignee
Proge Farm Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Proge Farm Srl filed Critical Proge Farm Srl
Application granted granted Critical
Publication of ATE419859T1 publication Critical patent/ATE419859T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
AT05778952T 2004-07-29 2005-07-28 Verwendung von probiotischen bakterien zur herstellung von topischen zusammensetzungen zum schutz der haut ATE419859T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT001550A ITMI20041550A1 (it) 2004-07-29 2004-07-29 Uso di batteri probiotici per la preparazione di composizioni topiche per la protezione dell'epidermide

Publications (1)

Publication Number Publication Date
ATE419859T1 true ATE419859T1 (de) 2009-01-15

Family

ID=35058737

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05778952T ATE419859T1 (de) 2004-07-29 2005-07-28 Verwendung von probiotischen bakterien zur herstellung von topischen zusammensetzungen zum schutz der haut

Country Status (7)

Country Link
EP (1) EP1778258B1 (de)
AT (1) ATE419859T1 (de)
DE (1) DE602005012276D1 (de)
ES (1) ES2320685T3 (de)
IT (1) ITMI20041550A1 (de)
PT (1) PT1778258E (de)
WO (1) WO2006013441A2 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2913337A1 (fr) * 2007-03-08 2008-09-12 Oreal Produit extemporane de soin a base d'un lyophilisat de microorganismes
JP2010531840A (ja) * 2007-06-27 2010-09-30 セーホーエル．ハンセン アクティーゼルスカブ アトピー性皮膚炎の治療のためのラクトバチルス・ヘルベティカス菌組成物
WO2010013182A1 (en) * 2008-07-29 2010-02-04 L'oreal Cosmetic use of microorganism(s) for the treatment of scalp disorders
FR2945944B1 (fr) * 2009-06-02 2011-07-15 Oreal Procede cosmetique de traitement des etats pelliculaires comprenant l'administration d'un microorganisme probiotique et d'un actif antipelliculaire
US8524220B1 (en) 2010-02-09 2013-09-03 David Gordon Bermudes Protease inhibitor: protease sensitivity expression system composition and methods improving the therapeutic activity and specificity of proteins delivered by bacteria
US9597379B1 (en) 2010-02-09 2017-03-21 David Gordon Bermudes Protease inhibitor combination with therapeutic proteins including antibodies
US8771669B1 (en) 2010-02-09 2014-07-08 David Gordon Bermudes Immunization and/or treatment of parasites and infectious agents by live bacteria
DE102011009798B4 (de) * 2011-01-31 2015-03-05 Merz Pharma Gmbh & Co. Kgaa Balneologische lipidhaltige probiotische Zubereitungen für kosmetische / dermatologische / medizinische Anwendungen
PL2704704T3 (pl) * 2011-05-03 2019-04-30 Dupont Nutrition Biosci Aps Bakterie probiotyczne do miejscowego leczenia zaburzeń skóry
IN2014DN07752A (de) 2012-02-29 2015-05-15 Ethicon Endo Surgery Inc
US9234204B2 (en) 2012-08-07 2016-01-12 TopGeniX, Inc. Topical composition comprising transformed bacteria expressing a compound of interest
FR2999601B1 (fr) 2012-12-17 2015-01-30 Urgo Lab Methode pour prevenir et/ou traiter les infections, colonisations ou maladies liees a staphylococcus aureus, pseudomonas aeruginosa, streptococcus pyogenes, enterococcus faecium, enterobacter cloacae, proteus mirabilis et/ou bacteroides fragilis
GR1008308B (el) 2013-05-31 2014-10-02 UNI-PHARMA ΚΛΕΩΝ ΤΣΕΤΗΣ ΦΑΡΜΑΚΕΥΤΙΚΑ ΕΡΓΑΣΤΗΡΙΑ ΑΒΕΕ με δ.τ. "UNI-PHARMA ABEE", Τοπικες φαρμακευτικες και ιατροτεχνολογικες συνθεσεις που περιεχουν συνδυασμους σουκραλφατης, υαλουρονικου οξεος, αργινινης και ενος φυσικου ενυδατικου παραγοντα
US9737592B1 (en) 2014-02-14 2017-08-22 David Gordon Bermudes Topical and orally administered protease inhibitors and bacterial vectors for the treatment of disorders and methods of treatment
KR20170019427A (ko) 2014-06-17 2017-02-21 탑제닉스, 인크. Ｕｖ 차단을 위한 국소용 제형
SG10201903823QA (en) 2014-10-31 2019-05-30 Whole Biome Inc Methods and compositions relating to microbial treatment and diagnosis of disorders
US10676723B2 (en) 2015-05-11 2020-06-09 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
WO2017173240A1 (en) 2016-03-31 2017-10-05 Gojo Industries, Inc. Antimicrobial peptide stimulating cleansing composition
AU2017240069B2 (en) 2016-03-31 2024-03-07 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
EP3435765A1 (de) 2016-03-31 2019-02-06 Gojo Industries, Inc. Desinfektionszusammensetzung zur stimulation von antimikrobiellen peptiden
ITUA20164065A1 (it) * 2016-06-01 2017-12-01 Probiotical Spa Composizioni in gel per applicazioni topiche a base di batteri, preparazione delle stesse e loro usi.
EP3544575A1 (de) 2016-11-23 2019-10-02 GOJO Industries, Inc. Desinfektionszusammensetzung mit probiotischem/präbiotischem wirkstoff
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
CN111372596A (zh) 2017-08-30 2020-07-03 潘德勒姆治疗公司 用于治疗微生物组相关病症的方法和组合物
IL276883B1 (en) * 2018-02-24 2026-04-01 Clearskin Ltd "Components, devices, systems, kits and methods for treating skin conditions"
IT201800004036A1 (it) * 2018-03-28 2019-09-28 Teres Srl Gel transdermico
AU2019274351B2 (en) 2018-05-23 2022-04-07 Kobiolabs, Inc. Lactobacillus gasseri KBL697 strain and use thereof
AU2019274350B2 (en) * 2018-05-23 2022-04-07 Kobiolabs, Inc. Lactobacillus crispatus KBL693 strain and use thereof
CA3106315A1 (en) 2018-07-19 2020-01-23 Pendulum Therapeutics, Inc. Methods and compositions for microbial engraftment
CA3123125A1 (en) 2019-01-04 2020-05-22 Lactobio A/S Strains, composition and method of use
IT201900000801A1 (it) * 2019-01-18 2020-07-18 Proge Farm Srl Composizione comprendente batteri probiotici non vitali e suo uso in terapia
CN114245748A (zh) * 2019-06-13 2022-03-25 莱托生物股份有限公司 包含活微生物的凝胶组合物
FR3117340B1 (fr) * 2020-12-15 2024-01-05 Basf Beauty Care Solutions France Sas Utilisation cosmétique, nutraceutique ou dermatologique d’une souche deLactobacillus crispatus et / ou d’une composition la comprenant
TW202330000A (zh) * 2021-12-10 2023-08-01 新加坡商百奧泰克斯私人有限公司 用於改善皮膚狀況之組合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1296148B1 (it) * 1996-11-22 1999-06-09 Renata Maria Anna Ve Cavaliere Uso di batteri lattici per accrescere il livello delle ceramidi della pelle e delle mucose, e composizioni dermatologiche e cosmetiche atte
EP1110555A1 (de) * 1999-12-22 2001-06-27 Societe Des Produits Nestle S.A. Anti-adhäsives Agens für die pathogene Hautflora

Also Published As

Publication number Publication date
ES2320685T3 (es) 2009-05-27
DE602005012276D1 (de) 2009-02-26
ITMI20041550A1 (it) 2004-10-29
EP1778258B1 (de) 2009-01-07
WO2006013441A3 (en) 2006-04-06
PT1778258E (pt) 2009-03-31
WO2006013441A2 (en) 2006-02-09
EP1778258A2 (de) 2007-05-02

Similar Documents

Publication Publication Date Title
ATE419859T1 (de) Verwendung von probiotischen bakterien zur herstellung von topischen zusammensetzungen zum schutz der haut
EA200870019A1 (ru) Лактамовые соединения и способы их применения
MX2009000285A (es) Piperidinas sustituidas que incrementan la actividad de p53 y usos de las mismas.
EP2494059A4 (de) Verwendung von methylsulfonylmethan (msm) zur modulierung einer mikrobiellen aktivität
ATE489957T1 (de) Mittel zur behandlung von entzündlichen erkrankungen
NO20083245L (no) Sykliske antimikrobielle peptider
DE602005015451D1 (de) Auf probiotischen bakterien basierende zusammensetzung und ihre verwendung zur vorbeugung und/oder behandlung von atemwegserkrankungen und/oder infektionen sowie zur verbesserung der darmtätigkeit
MY160041A (en) Compositions and methods for treating parasitic infections
DE602006021535D1 (de) Als inhibitoren von beta-secretase aktive tertiäre carbinamine mit substituierten heterocyclen zur behandlung der alzheimer-krankheit
ATE551063T1 (de) Verwendung von bifidobacterium longum zur prophylaxe und behandlung von entzündungen
WO2007131072A3 (en) Hydrolytically-resistant boron-containing therapeutics and methods of use
ATE526991T1 (de) Zusammensetzungen und ihre verwendungen für die gentherapeutische behandlung von knochenerkrankungen
ATE481134T1 (de) Zusammensetzungen und verwendung von tyrosinkinase-hemmern zur behandlung von pathogenen infektionen
CL2008002689A1 (es) Compuestos derivados de heterociclo 1,4 piperidina sustituida; compuestos intermediarios; composicion farmaceutica; proceso de preparacion; y su uso en el tratamiento del alzheimer y esquizofrenia.
ATE538799T1 (de) Zusammensetzungen zur behandlung von haarverlust
DE602004022689D1 (de) Verwendung probiotischer bakterien zur behandlung von infektionen
NO20055741D0 (no) Nye kjemiske forbindelser
TW200716091A (en) New therapeutic combinations for the treatment or prevention of psychotic disorders
ATE475651T1 (de) Aryl-substituierte heterozyklen und ihre verwendung
ATE524488T1 (de) Lysobactinamide
ATE361914T1 (de) Cathepsincysteinproteaseinhibitoren und deren verwendung zur behandlung von entzündungen und immunerkrankungen
IL178094A0 (en) Improvements in or relating to compounds for use in the treatment of aids and other viral diseases and hiv-related infections and compositions containing such compounds, methods of treating such diseases and infections and methods of making such compounds and compositions
UY31131A1 (es) "oxazolidinonas sustituidas y su uso
MX2007010484A (es) Moleculas y metodos para usarlas para tratar enfermedades asociadas con mcp-1/ccr2.
DE502005007472D1 (de) Desoxo-nonadepsipeptide

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties